Advertisement
Screener

Mersana Therapeutics, Inc. Financing Cash Flow

Mersana Therapeutics, Inc. Financing Cash Flow

Mersana Therapeutics, Inc. reported Financing Cash Flow of -$24.01 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-11-14

  • Mersana Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$17.76M.
  • Mersana Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was -$3.11M, a 2131.37% decline year-over-year.
  • Mersana Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was -$3.14M, a 153.82% decline year-over-year.
  • Mersana Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was -$1.87M, a 2129.35% decline year-over-year.
  • Mersana Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $4.09M, a 95.68% decline from fiscal 2023.
  • Mersana Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $94.67M, a 38.13% decline from fiscal 2022.
  • Mersana Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $153.02M, a 140.42% increase from fiscal 2021.
  • Mersana Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $63.65M, a 72.38% decline from fiscal 2020.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2025-09-30-$17.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$20.87M
derived: sum of 2 quarters · filed 2025-11-14
-$24.01M
10-Q · filed 2025-11-14
-$25.87M
derived: sum of 4 quarters · filed 2025-11-14
2025-06-30-$3.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
-$6.25M
10-Q · filed 2025-08-13
-$8.11M
derived: sum of 3 quarters · filed 2025-08-13
-$8.13M
derived: sum of 4 quarters · filed 2025-11-14
2025-03-31-$3.14M
10-Q · filed 2025-05-15
-$5.00M
derived: sum of 2 quarters · filed 2025-05-15
-$5.03M
derived: sum of 3 quarters · filed 2025-11-14
-$4.87M
derived: sum of 4 quarters · filed 2025-11-14
2024-12-31-$1.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
-$1.89M
derived: sum of 2 quarters · filed 2025-11-14
-$1.74M
derived: sum of 3 quarters · filed 2025-11-14
$4.09M
10-K · filed 2025-03-03
2024-09-30-$23.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$130.00K
derived: sum of 2 quarters · filed 2025-11-14
$5.96M
10-Q · filed 2025-11-14
$6.05M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$153.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$5.98M
10-Q · filed 2025-08-13
$6.07M
derived: sum of 3 quarters · filed 2025-08-13
$5.93M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$5.83M
10-Q · filed 2025-05-15
$5.92M
derived: sum of 2 quarters · filed 2025-05-15
$5.78M
derived: sum of 3 quarters · filed 2025-05-15
$78.95M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$92.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
-$54.00K
derived: sum of 2 quarters · filed 2025-03-03
$73.13M
derived: sum of 3 quarters · filed 2025-03-03
$94.67M
10-K · filed 2025-03-03
2023-09-30-$146.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$73.03M
derived: sum of 2 quarters · filed 2024-11-13
$94.58M
10-Q · filed 2024-11-13
$136.04M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30$73.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$94.73M
10-Q · filed 2024-08-13
$136.19M
derived: sum of 3 quarters · filed 2025-03-03
$146.82M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$21.55M
10-Q · filed 2024-05-09
$63.01M
derived: sum of 2 quarters · filed 2025-03-03
$73.64M
derived: sum of 3 quarters · filed 2025-03-03
$114.17M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31$41.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$52.10M
derived: sum of 2 quarters · filed 2025-03-03
$92.62M
derived: sum of 3 quarters · filed 2025-03-03
$153.02M
10-K · filed 2025-03-03
2022-09-30$10.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$51.16M
derived: sum of 2 quarters · filed 2023-11-07
$111.56M
10-Q · filed 2023-11-07
$140.35M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$40.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$100.92M
10-Q · filed 2023-08-08
$129.72M
derived: sum of 3 quarters · filed 2024-02-28
$130.18M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$60.39M
10-Q · filed 2023-05-09
$89.19M
derived: sum of 2 quarters · filed 2024-02-28
$89.65M
derived: sum of 3 quarters · filed 2024-02-28
$123.57M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$28.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$29.26M
derived: sum of 2 quarters · filed 2024-02-28
$63.17M
derived: sum of 3 quarters · filed 2024-02-28
$63.65M
10-K · filed 2024-02-28
2021-09-30$463.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$34.38M
derived: sum of 2 quarters · filed 2022-11-07
$34.85M
10-Q · filed 2022-11-07
$36.52M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$33.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$34.39M
10-Q · filed 2022-08-08
$36.05M
derived: sum of 3 quarters · filed 2023-02-28
$36.00M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$472.00K
10-Q · filed 2022-05-09
$2.14M
derived: sum of 2 quarters · filed 2023-02-28
$2.09M
derived: sum of 3 quarters · filed 2023-02-28
$230.97M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$1.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$1.62M
derived: sum of 2 quarters · filed 2023-02-28
$230.50M
derived: sum of 3 quarters · filed 2023-02-28
$230.41M
10-K · filed 2023-02-28
2020-09-30-$49.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$228.84M
derived: sum of 2 quarters · filed 2021-11-09
$228.75M
10-Q · filed 2021-11-09
$228.98M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$228.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$228.80M
10-Q · filed 2021-08-06
$229.03M
derived: sum of 3 quarters · filed 2022-02-28
$229.02M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$90.00K
10-Q · filed 2021-05-10
$141.00K
derived: sum of 2 quarters · filed 2022-02-28
$133.00K
derived: sum of 3 quarters · filed 2022-02-28
$5.41M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$231.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$223.00K
derived: sum of 2 quarters · filed 2022-02-28
$5.50M
derived: sum of 3 quarters · filed 2022-02-28
$97.70M
10-K · filed 2022-02-28
2019-09-30-$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$5.27M
derived: sum of 2 quarters · filed 2020-11-09
$97.47M
10-Q · filed 2020-11-09
$97.68M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$5.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$97.48M
10-Q · filed 2020-08-07
$97.69M
derived: sum of 3 quarters · filed 2021-02-26
$97.90M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$92.20M
10-Q · filed 2020-05-08
$92.42M
derived: sum of 2 quarters · filed 2021-02-26
$92.62M
derived: sum of 3 quarters · filed 2021-02-26
$93.01M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$211.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$420.00K
derived: sum of 2 quarters · filed 2021-02-26
$809.00K
derived: sum of 3 quarters · filed 2021-02-26
$1.06M
10-K · filed 2021-02-26
2018-09-30$209.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$598.00K
derived: sum of 2 quarters · filed 2019-11-06
$853.00K
10-Q · filed 2019-11-06
$874.00K
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$389.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$644.00K
10-Q · filed 2019-08-08
$665.00K
derived: sum of 3 quarters · filed 2020-02-28
$71.31M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$255.00K
10-Q · filed 2019-05-09
$276.00K
derived: sum of 2 quarters · filed 2020-02-28
$70.92M
derived: sum of 3 quarters · filed 2020-02-28
$69.25M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$70.66M
derived: sum of 2 quarters · filed 2020-02-28
$69.00M
derived: sum of 3 quarters · filed 2020-02-28
$68.60M
10-K · filed 2020-02-28
2017-09-30$70.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$68.98M
derived: sum of 2 quarters · filed 2018-11-13
$68.58M
10-Q · filed 2018-11-13
$68.60M
derived: sum of 4 quarters · filed 2019-03-08
2017-06-30-$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
-$2.06M
10-Q · filed 2018-08-14
-$2.04M
derived: sum of 3 quarters · filed 2019-03-08
-$2.08M
derived: sum of 4 quarters · filed 2019-03-08
2017-03-31-$401.00K
10-Q · filed 2018-05-15
-$377.00K
derived: sum of 2 quarters · filed 2019-03-08
-$414.00K
derived: sum of 3 quarters · filed 2019-03-08
2016-12-31$24.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08
-$13.00K
derived: sum of 2 quarters · filed 2019-03-08
$58.26M
10-K · filed 2019-03-08
2016-09-30-$37.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$58.23M
10-Q · filed 2017-11-13
2016-06-30$58.27M
10-Q · filed 2017-08-11
2015-12-31$9.96M
10-K · filed 2018-03-28